
King's International visiting fellowships in movement disorders and Neuro-rehabilitation
King's Dubai's Parkinson's Centre of Excellence is pioneering international clinical and research training fellowships, including the first-ever Indonesian Visiting Program in Dubai.
Dr. Merrie, a consultant in neurorehabilitation at EMC Hospitals in Jakarta, completed her fellowship in Movement Disorders and Parkinson's at King's College Hospital london-Dubai under the supervision of Dr. Vinod Metta, the program director.
She praised the entire training program, noting her experience managing not only advanced Parkinson's patients but also complicated movement disorders. Dr. Merrie expressed her gratitude for the opportunity to witness rare neurological conditions such as corticobasal degeneration, ocular apraxia, and alien limb syndrome—diseases she had only encountered in textbooks.
Additionally, she gained hands-on experience treating patients with dystonia and spasticity through EMG-guided botulinum injections and managing elevated intracranial pressure, all under the mentorship of Dr. Metta and Professor Ray Chaudhuri.
Mr. Mohammed, a neuro-physiotherapist, also participated in the customized Parkinson's neurorehabilitation training program under Dr. Metta's supervision. He was thrilled to share his experiences, particularly how the Parkinson's Centre of Excellence effectively manages advanced Parkinson's cases across diverse races, ages, and stages with a dedicated team of neurophysiotherapists, speech and language therapists, and occupational therapists. He was impressed by the outcomes achieved and noted that this fellowship training provided him with invaluable experience in dealing with complex Parkinson's and movement disorder cases in Jakarta.
Both Dr. Merrie and Mr. Mohammed expressed their gratitude to the management of EMC Hospitals—Pak Jusup, Dr. Juni, Dr. Metta, and Dr. Sedjaya—for nominating them for this prestigious Indonesian overseas training program, as well as to the management team at King's Dubai, including Ms. Kimberley Pierce and Ms. Norafiz Gee, for their support.
They especially thanked the program directors, Dr. Vinod Metta and Professor Ray Chaudhuri, along with all mentors, including Dr. Guy Chung-Faye, Dr. George Kapsas, Dr. Nicandro, and Dr. John.
Dr. Vinod Metta, the Program Director, remarked that the Parkinson's Centre of Excellence at King's Dubai offers exceptional visiting training fellowships. These programs provide neurology residents, junior neurologists, neuro-rehabilitation consultants, and neuro-physiotherapists with comprehensive, hands-on training to manage a range of movement disorders and Parkinson's disease while gaining expertise in neuro-physiology, neuro-radiology, and neuro-spine. He expressed his satisfaction in receiving positive feedback from the first group of visiting fellows.
King's Parkinson's Centre of Excellence
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Middle East Eye
3 days ago
- Middle East Eye
Bombing hospitals is a red line - unless Israel is doing it
On Thursday morning, Iranian missiles struck Soroka hospital in Beersheba, triggering expressions of outrage from Israeli officials. National Security Minister Itamar Ben Gvir likened the Iranian regime to 'Nazis who fire missiles at hospitals, the elderly and children'. President Isaac Herzog evoked imagery of a baby in intensive care and a doctor rushing between beds. Culture Minister Miki Zohar declared on social media that 'only the scum of the earth fires missiles at hospitalized children and elderly people in their sick beds'. The chair of Israel's medical association, Zion Hagay, decried the strike as a war crime and urged the international medical community to condemn it. This swift and unified condemnation by Israeli political and medical leadership underscores a striking contradiction: these same actors not only ignored but openly justified the destruction of Gaza's hospitals over the past two years. Since 7 October 2023, Israeli air strikes and ground invasions have decimated Gaza's healthcare infrastructure. The World Health Organisation has recorded around 700 attacks on healthcare facilities. Major hospitals - al-Shifa, Nasser and the Indonesian hospital, among others - have been besieged, bombed and dismantled. New MEE newsletter: Jerusalem Dispatch Sign up to get the latest insights and analysis on Israel-Palestine, alongside Turkey Unpacked and other MEE newsletters Israeli officials frame these hospitals as military targets and Hamas 'shields'. Shifa, the largest hospital in Gaza, was placed under siege and then invaded, with the attack hailed by Israeli media as a victory. Meanwhile, the Israeli Medical Association remained silent. In one of its rare statements after a year and a half of Israel's repeated and targeted attacks on hospitals and civilian infrastructure, the association echoed the state's narrative, stating that health facilities and personnel must not be targeted 'unless these are being used as a base for terrorist activities'. Selective moral outrage What is especially striking about this moment is the selective moral outrage from Israeli officials. The same ministers who justified the systematic dismantling of Gaza's healthcare system now describe an attack on an Israeli hospital as a red line, a war crime. Herzog's sentimental imagery of doctors rushing between beds evokes the stark reality in Gaza, where health workers have been shot and shelled in operating rooms, imprisoned, or forced to abandon their patients under fire. International medical voices have played along. While many doctors and health workers have spoken out, many others have remained silent, with no real actions taken to hold Israel accountable. Follow Middle East Eye's live coverage of the Israel-Palestine war It would be a mistake to treat these official statements as being detached from the public mood in Israel. Most Israelis have defended the destruction of Gaza's healthcare infrastructure. Public discourse has normalised the idea that Palestinian hospitals are legitimate military targets, even celebrating their destruction in some cases. This normalisation is not incidental. It is part of a broader dehumanisation of Palestinians, where even a child under anaesthesia in a Gaza operating room is not seen as a victim, but as collateral damage or a 'shield'. The outrage over Soroka thus reveals a deeper truth: in the eyes of many institutions and audiences, some lives are inherently more valuable than others. When Israeli hospitals are struck, the world responds with empathy and urgency. When Palestinian hospitals are dismantled - patients killed in their beds, doctors arrested mid-surgery - the world hesitates, rationalises or remains silent. How can Palestinian medics 'cooperate' with Israeli health bodies during a genocide? Read More » This is not simply a double standard; it reflects an entrenched hierarchy of whose suffering matters. Israeli leaders speak today of moral lines, of civilians and children, of hospitals as sanctuaries. Yet for nearly two years, those very values have been systematically violated in Gaza, with hardly a whisper of regret. This situation reveals not only hypocrisy but also the cynical confidence that comes with impunity. It reflects how the boundaries of Israeli grief and outrage are drawn narrowly around Jewish Israeli lives, grounded in the certainty that Israel will face no consequences. This moment puts the international system to the test. While some medical and humanitarian groups have expressed concern, most international stakeholders have remained silent in the face of the destruction of Gaza's entire health system. Will medical journals, international associations and UN bodies respond to the attack on an Israeli hospital with the kind of swift condemnation and concrete actions they failed to take when hospitals in Gaza were bombed? The world should have acted when the first operating room was hit in Gaza. It should not take an Israeli facility being targeted for them to remember that hospitals are meant to be protected spaces. If an attack on a hospital is a red line, this must be true for all hospitals, not just those serving Israelis. If international law is to mean anything, it must protect everyone, with the same standards applied to every violation. Anything less is not only hypocrisy; it is complicity. The views expressed in this article belong to the author and do not necessarily reflect the editorial policy of Middle East Eye.


Al Etihad
6 days ago
- Al Etihad
Cleveland Clinic Abu Dhabi delivers first infusion therapy for Parkinson's in region
17 June 2025 11:31 ABU DHABI (WAM) Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge therapeutic treatment for advanced Parkinson's disease, making it the first hospital in the GCC region to offer this innovative therapy offers a groundbreaking alternative for patients who are not candidates for DBS or prefer a non-invasive all patients in the advanced stages of Parkinson's are eligible for it. It delivers a continuous subcutaneous infusion of levodopa-carbidopa—the gold-standard medication for Parkinson's—through a compact pump connected to the skin. Unlike oral medications, which can lead to fluctuating absorption and inconsistent symptom control, this approach provides a steady, around-the-clock infusion, ensuring more stable symptom post-treatment follow-ups are significantly reduced to once every six months, compared to the frequent monitoring required after DBS surgery, making it a more convenient long-term option for by an exceptional team of Parkinson's disease specialists providing 24/7 care, alongside a dedicated rehabilitation team and other medical professionals, Cleveland Clinic Abu Dhabi ensures patients receive the highest level of comprehensive, patient-centred on bringing advanced and tailored treatment solutions to the region, Dr. Georges-Pascal Haber, the CEO of Cleveland Clinic Abu Dhabi, said, 'The introduction of continuous therapy in the UAE and GCC represents a critical advancement in how we approach patient care and outcomes in the region. As neurodegenerative diseases become more prevalent, patients are increasingly in need of personalised, innovative solutions.'Highlighting the impact of the therapy, Dr. Shivam Om Mittal, Staff Physician, Neurological Institute at Cleveland Clinic Abu Dhabi, who led the treatment, said, 'We are proud to be the first in the region to offer this groundbreaking therapy so soon after its global introduction. At Cleveland Clinic Abu Dhabi, we provide a full spectrum of advanced Parkinson's treatments—including oral medication, deep brain stimulation (DBS), and now this treatment, ensuring each patient receives a personalised care plan. Additionally, our exceptional team of Parkinson's disease specialists, supported by a dedicated rehabilitation team and other medical professionals, ensures 24/7 care and comprehensive support for our patients at every stage of their journey.'The infusion system functions much like an insulin pump, with a compact, phone-sized device connected to a fine tube placed on the skin. It delivers a continuous infusion of Parkinson's medication throughout the day and night, maintaining stable drug levels and significantly reducing motor fluctuations and innovation is transforming how we manage advanced Parkinson's disease, offering patients greater stability, independence, and an improved quality of life. Additionally, its straightforward design makes it easy to implement, providing a seamless transition for both patients and Parkinson's disease being the fastest-growing neurodegenerative condition worldwide—expected to double by 2040—the need for innovative, effective treatments has never been more urgent. Currently, 1% of individuals over 60 years old are affected globally, with an increasing number of young-onset cases under 50 being its introduction in 2019 by Cleveland Clinic Abu Dhabi, deep brain stimulation (DBS) surgery has been the leading advanced treatment for Parkinson's in the UAE. The hospital has now successfully performed over 100 Clinic Abu Dhabi, through the pioneering introduction of continuous infusion therapy in the GCC, is leading the charge in neurological marks a significant step forward in the UAE's ambition to become a global hub for medical innovation. With its multidisciplinary approach to patient care, where neurology, surgery, rehabilitation, and other specialities collaborate seamlessly, it continues to set new standards in advancing treatment options that transform patient outcomes and improve lives across the region.


TECHx
12-06-2025
- TECHx
King Faisal Hospital Reveals AI Brain Implant Breakthrough
Home » Middle East » King Faisal Hospital Reveals AI Brain Implant Breakthrough King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced a major medical milestone. It has become the first institution in the Middle East to implant an AI-powered brain-sensing device. The technology is designed to treat complex neurological disorders. According to the hospital, the breakthrough marks the start of a new era in neuromodulation therapy. The device offers real-time, adaptive treatment for patients with conditions such as Parkinson's disease, epilepsy, and other movement disorders. KFSHRC revealed that the device uses artificial intelligence to monitor brain activity continuously. It identifies abnormal signals and sends precise electrical impulses to restore balance. This closed-loop system allows real-time adjustments based on the brain's activity. As a result, patients receive personalized therapy and consistent symptom control throughout the day. The hospital reported that the procedure is minimally invasive. It typically takes between three to five hours to complete. The new device may reduce reliance on medication by up to 50%. It also aims to improve patients' autonomy and quality of life. KFSHRC noted that patients show rapid recovery after surgery. Many report improved symptom control within weeks. This development highlights the leadership of KFSHRC's Neuroscience Centre of Excellence. The center provides multidisciplinary care for adult and paediatric cases. It leads in deep brain stimulation for movement disorders and stereotactic EEG for epilepsy. It also pioneers AI-based diagnostics for cognitive conditions and autism. The hospital emphasized its commitment to innovation and patient-centered care. It aims to set new standards in precision brain health. Recently, KFSHRC was ranked first in the Middle East and Africa and 15th globally among the world's top 250 academic medical centres. The 2025 Brand Finance report also recognized it as the most valuable healthcare brand in the region. In addition, Newsweek included KFSHRC in its 2025 list of the World's Best Smart Hospitals.